CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- CERT Other Certification
- 25 Other Notification of Removal from Listing
- 8-A12B Other Registration of Securities
- S-3MEF Other S-3MEF
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- PRER14A Other PRER14A
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- D Other Notice of Sales of Unregistered Securities
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- PRE 14C Other PRE 14C
Page 2 of 3 · 59 filings